Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00653224 · ClinicalTrials.gov registry record · Phase 4

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

A Phase 4 study of Seasonal Allergic Rhinitis, sponsored by UCB Pharma.

Completed
Registry status
Phase 4
Development phase
580
Enrollment target
20
Study locations

NCT00653224 is a Phase 4 study of Seasonal Allergic Rhinitis that has completed, run by UCB Pharma. The registered enrollment target is 580 participants, roughly in line with the 632-participant average among 16 other Seasonal Allergic Rhinitis trials with a reported enrollment target. The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00653224, a Phase 4 study of Seasonal Allergic Rhinitis, has completed, sponsored by UCB Pharma.

COMPLETED
Registry status
Phase 4
Development phase
580 participants
Enrollment target
20
Study locations

Study Summary

The study objective is to investigate the efficacy of levocetirizine in reducing symptoms associated with seasonal allergic rhinitis and in improving rhinitis-related Quality of Life.

Conditions Studied

Seasonal Allergic Rhinitis

Interventions

  • DRUG placebo
  • DRUG levocetirizine dihydrochloride

Study Locations (20)

California

  • - Los Angeles
  • - Sacramento
  • - San Francisco
  • - San Jose

Georgia

  • - Atlanta
  • - Gainesville
  • - Lawrenceville
  • - Stockbridge

Colorado

  • - Colorado Springs
  • - Denver

Massachusetts

  • - Harvard
  • - North Dartmouth

New Jersey

  • - Berlin
  • - Skillman

Arizona

  • - Tucson

Florida

  • - Miami

Illinois

  • - Normal

Trial Details

FieldValue
Enrollment Target 580 participants
Start Date 2008-04
Est. Completion 2008-07
Phase Phase 4

Sponsor

UCB Pharma

100 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00653224

The ClinicalTrials.gov registry entry for NCT00653224 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 580 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 632-participant average among 16 other Seasonal Allergic Rhinitis trials with a reported enrollment target. The listed sponsor is UCB Pharma, which has 100 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Seasonal Allergic Rhinitis appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00653224 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Georgia, Colorado.

Frequently Asked Questions

What is clinical trial NCT00653224 about?

NCT00653224 is a clinical study titled "A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis". The study objective is to investigate the efficacy of levocetirizine in reducing symptoms associated with seasonal allergic rhinitis and in improving rhinitis-related Quality of Life.

What is the current status of trial NCT00653224?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 580 participants. The study started on 2008-04. Estimated completion is 2008-07.

What conditions does trial NCT00653224 study?

This clinical trial studies the following conditions: Seasonal Allergic Rhinitis.

What interventions are being tested in trial NCT00653224?

The interventions under investigation include: placebo (DRUG), levocetirizine dihydrochloride (DRUG).

Who is sponsoring clinical trial NCT00653224?

This trial is sponsored by UCB Pharma, which has 100 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00653224 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Seasonal Allergic Rhinitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Seasonal Allergic Rhinitis

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.